OLIVIA BRADSHAW: Open Payments
NPI 1407443161 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$169 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $169
Food & beverage: $169
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
Products named: CAPLYTA, BREZTRI, VOQUEZNA, MOUNJARO, TRELEGY ELLIPTA, Rybelsus, Cologuard Collection Kit, REXULTI.
Industry payments across IN — which companies pay providers there.
